MX9706967A - Indazolcarboxamidas. - Google Patents

Indazolcarboxamidas.

Info

Publication number
MX9706967A
MX9706967A MX9706967A MX9706967A MX9706967A MX 9706967 A MX9706967 A MX 9706967A MX 9706967 A MX9706967 A MX 9706967A MX 9706967 A MX9706967 A MX 9706967A MX 9706967 A MX9706967 A MX 9706967A
Authority
MX
Mexico
Prior art keywords
indazolecarboxamides
receptor
dysfunction
antagonists
affected
Prior art date
Application number
MX9706967A
Other languages
English (en)
Other versions
MXPA97006967A (es
Inventor
John Thomas Catlow
Marlene Lois Cohen
Michael John Martinelli
John Mehnert Schaus
Steven Phillip Swanson
Dennis Charles Thompson
Thomas Michael Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/485,956 external-priority patent/US5654320A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9706967A publication Critical patent/MX9706967A/es
Publication of MXPA97006967A publication Critical patent/MXPA97006967A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paper (AREA)
  • Luminescent Compositions (AREA)

Abstract

Las indazolcarboxamidas se usan como antagonistas y agonistas parciales del receptor 5-HT4 de la serotonina y proporcionan métodos terapéuticos para el tratamiento de desordenes causados por o afectados por la disfuncion del receptor 5-HT4.
MXPA/A/1997/006967A 1995-03-16 1997-09-12 Indazolcarboxamidas MXPA97006967A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US40511995A 1995-03-16 1995-03-16
US405119 1995-03-16
US405,119 1995-03-16
US08/485,956 US5654320A (en) 1995-03-16 1995-06-07 Indazolecarboxamides
US08485956 1995-06-07
PCT/US1996/003551 WO1996033713A1 (en) 1995-03-16 1996-03-14 Indazolecarboxamides

Publications (2)

Publication Number Publication Date
MX9706967A true MX9706967A (es) 1997-11-29
MXPA97006967A MXPA97006967A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
PL183867B1 (pl) 2002-07-31
GR3037029T3 (en) 2002-01-31
NZ315971A (en) 1999-01-28
EP0732333A1 (en) 1996-09-18
NO974221D0 (no) 1997-09-12
CN1112923C (zh) 2003-07-02
IL117438A0 (en) 1996-07-23
EP0732333B1 (en) 2001-08-01
ATE203748T1 (de) 2001-08-15
HUP9801386A3 (en) 2000-03-28
DK0732333T3 (da) 2001-10-08
RO119617B1 (ro) 2005-01-28
AU700842B2 (en) 1999-01-14
HU223973B1 (hu) 2005-03-29
TR199700956T1 (xx) 1998-02-21
US5817676A (en) 1998-10-06
DE69614164D1 (de) 2001-09-06
EA000699B1 (ru) 2000-02-28
HUP9801386A2 (hu) 1999-06-28
IL117438A (en) 2001-12-23
PT732333E (pt) 2001-11-30
DE69614164T2 (de) 2002-04-25
EA199700242A1 (ru) 1998-04-30
SK283924B6 (sk) 2004-05-04
NO312833B1 (no) 2002-07-08
CN1183041A (zh) 1998-05-27
NO974221L (no) 1997-10-27
BR9608223A (pt) 1998-12-29
CA2215359A1 (en) 1996-10-31
AU6894896A (en) 1996-11-18
ES2159345T3 (es) 2001-10-01
US5798367A (en) 1998-08-25
SK124297A3 (en) 1998-02-04
PL322362A1 (en) 1998-01-19
WO1996033713A1 (en) 1996-10-31
JPH11502230A (ja) 1999-02-23

Similar Documents

Publication Publication Date Title
HUT74992A (en) Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia
MY131298A (en) 5-heteroyl indole derivatives
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
MY132229A (en) Indole derivatives as 5-ht receptor antagonist
NO20003550L (no) Farmasøytiske sammensetninger og anvendelse herav
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
NZ332780A (en) Substituted amines for the treatment of neurological and neuropsychiatric disorders
EA199800340A1 (ru) Производные пиримидина как антагонисты 5нт2с
YU59098A (sh) Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
HU9503826D0 (en) Heterocycles useful as neurokinin antagonists
PT1666462E (pt) Derivados de n-[1h-indol-5-il]-naftaleno-1-sulfonamida e compostos associados enquanto antagonistas do receptor 5- ht6 de serotonina para o tratamento de distúrbios do sistema nervoso central
NZ334029A (en) Use of serotonin 5-HT1F agonist for the treatment of common colds or allergic rhinitis
TR199700956T1 (xx) Indazolkarboksamidler.
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
GR3019782T3 (en) Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
AU3745795A (en) Use of CCK-B receptor antagonists for the treatment of sleepdisorders
WO1993023035A3 (en) Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
MY107354A (en) Substituted cyclohexenes as central nervous system agents
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
EP0976747A3 (en) Use of 5HT-1F receptor antagonists for treating anxiety disorders
NO20012538D0 (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
IT1294932B1 (it) Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees